Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CELLINK

Explore full profile

The world’s leading bioconvergence company

Göteborgs Stad, SwedenFounded 2016Biotech & Life Sciences
Valuation $116M Market cap · Aug/2026
Revenue $214M Latest reported FY
EBITDA $15M Latest reported FY

At a glance

Founded
2016
Headquarters
Göteborgs Stad, Sweden
Listing
IPO 2016
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
Market map US Novel Energy Startups Jun 25, 2026 Market map 200 Microfluidics startups Market map Tech based alternatives to animal testing

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Bosch Ventures

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇸🇪 Sweden67.7%
🇺🇸 United States19.6%
🇸🇬 Singapore3.7%
🇮🇳 India2.6%
🇪🇸 Spain2.1%
Top 5 of 10 shown
Web traffic by country
71K monthly visits
across markets
🇮🇳 India25.9%
🇮🇪 Ireland14.8%
🇺🇸 United States12.8%
🇸🇪 Sweden4.9%
🏳️ Korea4.6%
Top 5 markets shown

Patents

Estimated portfolio value
$84M

141 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where CELLINK was the backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across CELLINK's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        CELLINK's portfolio, mapped.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about CELLINK on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See CELLINK on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles